OR WAIT 15 SECS
At SupplySide East, representatives from Evolva discussed the latest developments for the company’s resveratrol ingredients.
At SupplySide East, resveratrol supplier Evolva (Reinach, Switzerland) discussed the latest developments around the company’s brand-name resveratrol ingredients.
Studies in the Pipeline
Evolva is awaiting the results of what the company says will be the largest and longest study ever to exist on resveratrol. The two-year study1, called RESHAW (“Supporting Healthy Aging in Women with Resveratrol”), is being conducted by University of Newcastle, Australia, researchers in menopausal women and examining the effects of Evolva’s flagship Veri-te resveratrol ingredient on cognition, mood, physical function, and bone mineral density loss associated with menopause, the company says. The study is expected to be completed by the end of this year.
Another study2 is examining the effects of Veri-te resveratrol supplementation on cognitive function, gut microbiota, and cerebral blood flow. The study, being conducted by researchers from The Brain Performance and Nutrition Research Centre at Northumbria University in the UK, is investigating the relationship between gastrointestinal microbiota, inflammation, diet, and brain function, says Evolva. The first part of this three-part study is expected to be completed by the end of this July, the company adds.
Expanding Delivery Formats and Market Interest
The company says it also continues to see interest grow in the new water-dispersible version of its resveratrol ingredient, introduced at last year’s SupplySide West show. Originally named Veri-te Resveratrol CWD 90, the ingredient was recently rebranded with the name Veri-Sperse.
The ingredient was created using LipiSperse dispersion technology from Pharmako Biotechnologies (Australia), which ultimately renders the resveratrol-which otherwise is not water soluble-dispersible and ready for use in liquid formulations and instant powder beverages. At SupplySide East, David Tetzlaf, senior marketing manager for Evolva, said that a study examining the potential increased bioavailability that the dispersible Veri-Sperse offers may be completed later this year.
Tetzlaf said it’s exciting to see its resveratrol in more products on the market. At SupplySide East, he told Nutritional Outlook, “The trend that we’re seeing, which is really exciting, is more companies using resveratrol in combination with other ingredients. While we’d love to sell resveratrol alone, it’s great seeing it going into other areas where maybe consumers are just becoming aware of resveratrol in some ways. So, people might be buying something because they’re familiar with some of the other ingredients and now they’ll begin to see that resveratrol supports cognition and other health concerns as well.”